Been here 7 years, and all I got was this lousy...

Discussion in 'Avanir Pharmaceuticals' started by anonymous, Aug 20, 2017 at 8:36 PM.

Tags: Add Tags
  1. #1 anonymous, Aug 20, 2017 at 8:36 PM
    anonymous

    anonymous Guest

    Let the exodus begin
     
    Quote

  2. #2 anonymous, Aug 20, 2017 at 9:11 PM
    anonymous

    anonymous Guest

    ...and all i got was this lousy product to sell
     
    Quote
  3. #3 anonymous, Aug 29, 2017 at 8:16 PM
    anonymous

    anonymous Guest

    nuedexta was a great drug to sell, picking up ONZETRA could end up being the worst purchase of a product EVER

    if they would have stuck with one drug it would still be a great place to work
     
    Quote
  4. #4 anonymous, Aug 29, 2017 at 8:57 PM
    anonymous

    anonymous Guest

    I doubt the PNAMs would agree!
     
    Quote
  5. #5 anonymous, Aug 29, 2017 at 9:19 PM
    anonymous

    anonymous Guest

    The goal is not to sell the generic migraine drug to take a big market share. The goal is to market the the goofy delivery system that provides expedited efficacy. Patent royalties.
     
    Quote
Reply to Thread